In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes

Clinical and Experimental Immunology

Volumn 143, Issue 2, 2006, Pages 338-344

  Telino, E ^a   De Luca, P M ^a   Matos, D C S ^a   Azeredo Coutinho, R B ^a   Meirelles, M N ^a   Conceicao Silva F ^a   Schubach, A ^b   Mendonca S C F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

American tegumentary leishmaniasis; Antigen fractions; Cytokines; Leishmania amazonensis; Leishmania braziliensis

Indexed keywords

CELL EXTRACT; GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN;

ANTIGENICITY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON PRODUCTION; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMASTIGOTE; STIMULATION; WHOLE CELL; ANIMAL; CELL DIVISION; ELECTRON MICROSCOPY; IMMUNOLOGY; MONONUCLEAR CELL; SKIN LEISHMANIASIS; SOLUBILITY; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, PROTOZOAN; CELL DIVISION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, ELECTRON; SOLUBILITY;

EID: 33644849916     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.02995.x     Document Type: Article

References (41)

1. Bates PA Rogers ME New insights into the developmental biology and transmission mechanisms of Leishmania Curr Mol Med 2004 4 601 9
2. Silveira FT Lainson R Corbett CE Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review Mem Inst Oswaldo Cruz 2004 99 239 51
3. Desjeux P Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis 2004 27 305 18
4. Desjeux P The increase in risk factors for the leishmaniasis Worldwide Trans R Soc Trop Med Hyg 2001 95 239 43
5. Modabber F Vaccines against leishmaniasis Ann Trop Med Parasitol 1995 89 83 8
6. Mayrink W da Costa CA Magalhaes PA Melo MN Dias M Lima AO Michalick MS Williams P A field trial of a vaccine against American dermal leishmaniasis Trans R Soc Trop Med Hyg 1979 73 385 7
7. Mendonca SC De Luca PM Mayrink W et al. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis Am J Trop Med Hyg 1995 53 195 201
8. De Luca PM Mayrink W Alves CA et al. Evaluation of the stability and immunogenicity of autoclaved and non-autoclaved preparations of a vaccine against American tegumentary leishmaniasis Vaccine 1999 17 1179 85
9. Marzochi KB Marzochi MA Silva AF Grativol N Duarte R Confort EM Modabber F Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil Mem Inst Oswaldo Cruz 1998 93 205 12
10. De Luca PM Mayrink W Pinto JA et al. A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis Acta Trop 2001 80 251 60
11. Velez ID Gilchrist K Arbelaez MP Rojas JA Puerta JA Antunes CM Zicker F Modabber F Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia Trans R Soc Trop Med Hyg 2005 99 593 8
12. Salman SM Rubeiz NG Kibbi AG Cutaneous leishmaniasis. clinical features and diagnosis Clin Dermatol 1999 17 291 6
13. Da Costa CA Toledo VPCP Genaro O Williams P Mayrink W Leishmanin skin test - Evaluation of the composition and stability of the antigen preparation Mem Inst Oswaldo Cruz 1996 91 193 4
14. Badaro R Pedral-Sampaio D Johnson WD Jr. Reed SG Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis Trans R Soc Trop Med Hyg 1990 84 226 7
15. Scott P Pearce E Natovitz P Sher A Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes J Immunol 1987 139 221 7
16. de Oliveira-Neto MP Mattos MS Perez MA et al. American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics Int J Dermatol 2000 39 506 14
17. Castes M Agnelli A Verde O Rondon AJ Characterization of the cellular immune response in American cutaneous leishmaniasis Clin Immunol Immunopathol 1983 27 176 86
18. Carvalho EM Barral A Costa JM Bittencourt A Marsden P Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis Acta Trop 1994 56 315 25
19. Mendonca SC Coutinho SG Amendoeira RR Marzochi MC Pirmez C Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil. lymphoproliferative responses and influence of therapy Clin Exp Immunol 1986 64 269 76
20. Cupolillo E Grimaldi G Jr. Momen H A general classification of New world Leishmania using numerical zymotaxonomy Am J Trop Med Hyg 1994 50 296 311
21. De Luca PM Mayrink W Santiago MA Nogueira R Conceição-Silva F Mélo G Mendonca SCF Randomised, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test Trans R Soc Trop Med Hyg 2003 97 709 12
22. Matos DS Azeredo-Coutinho RB Schubach A Conceição-Silva F Baptista C Moreira JS Mendonca SC Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy Clin Infect Dis 2005 40 e5 12
23. Silveira FT Blackwell JM Ishikawa EA et al. T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia Parasite Immunol 1998 20 19 26
24. Bacellar O Lessa H Schriefer A Machado P Ribeiro de Jesus A Dutra WO Gollob KJ Carvalho EM Up-regulation of Th1-type responses in mucosal leishmaniasis patients Infect Immun 2002 70 6734 40
25. Convit J Ulrich M Fernandez CT Tapia FJ Caceres-Dittmar G Castes M Rondon AJ The clinical and immunological spectrum of American cutaneous leishmaniasis Trans R Soc Trop Med Hyg 1993 87 444 8
26. Pinheiro RO Pinto EF Benedito AB Lopes UG Rossi-Bergmann B The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis An Acad Bras Cienc 2004 76 519 27
27. Nylen S Mortbert U Kovalenko D Satti I Engstrom K Bakhiet M Akuffo H Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors Clin Exp Immunol 2001 124 43 53
28. Garg R Gupta SK Tripathi P Naik S Sundar S Dube A Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani Clin Exp Immunol 2005 140 149 56
29. Yao C Donelson JE Wilson ME The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function Mol Biochem Parasitol 2003 132 1 16
30. Afrin F Rajesh R Anam K Gopinath M Pal S Ali N Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice Infect Immun 2002 70 6697 706
31. Tsagozis P Karagouni E Dotsika E Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis Int J Immunopathol Pharmacol 2004 17 343 52
32. Xu D Liew FY Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. Major Immunol 1995 84 173 6
33. Connell ND Medina-Acosta E McMaster WR Bloom BR Russell DG Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63 Proc Natl Acad Sci USA 1993 90 11473 7
34. McSorley SJ Xu D Liew FY Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters Infect Immun 1997 65 171 8
35. Russo DM Turco SJ Burns JM Jr. Reed SG Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins J Immunol 1992 148 202 7
36. Kurtzhals JA Hey AS Jardim A Kemp M et al. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients Clin Exp Immunol 1994 96 416 21
37. Vinhas V Freire M Bacellar O Cunha S Rocha H Carvalho EM Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi Braz J Med Biol Res 1994 27 1199 205
38. Ramirez JR Gilchrist K Robledo S Sepulveda JC Moll H Soldati D Berberich C Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice Vaccine 2001 20 455 61
39. Basu R Bhaumik S Basu JM De Naskar KT Roy S Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and - resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis J Immunol 2005 174 7160 71
40. Copland MJ Rades T Davies NM Baird MA Lipid based particulate formulations for the delivery of antigen Immunol Cell Biol 2005 83 97 105
41. Machado-Pinto J Pinto J da Costa CA Genaro O Marques MJ Modabber F Mayrink W Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial Int J Dermatol 2002 41 73 8